{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:59:20Z","timestamp":1792569560778,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"am","delay-in-days":401,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The French Journal of Urology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.purol.2023.10.001","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T10:42:25Z","timestamp":1697539345000},"page":"102547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Significant prostate cancer risk after MRI-guided biopsy showing benign findings: Results from a cohort of 381 men"],"prefix":"10.1016","volume":"34","author":[{"given":"V.T.","family":"Dang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"P\u00e9ricart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Manceau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Aziza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Portalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lagarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Souli\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Gam\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Malavaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Thoulouzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Doumerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Prudhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ploussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Roumigui\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.purol.2023.10.001_bib0140","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u00a0\u2013\u00a02020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.purol.2023.10.001_bib0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.eururo.2012.06.004","article-title":"Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review","volume":"63","author":"Moore","year":"2013","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.purol.2023.10.001_bib0150","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.juro.2015.10.140","article-title":"The diagnostic performance of multiparametric magnetic resonance imaging to detect significant prostate cancer","volume":"195","author":"Thompson","year":"2016","journal-title":"J Urol"},{"issue":"19","key":"10.1016\/j.purol.2023.10.001_bib0155","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"issue":"10071","key":"10.1016\/j.purol.2023.10.001_bib0160","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.purol.2023.10.001_bib0165","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41391-021-00417-1","article-title":"Cancer detection rates of the PI-RADSv2.1 assessment categories: systematic review and meta-analysis on lesion level and patient level","volume":"25","author":"Oerther","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1016\/j.purol.2023.10.001_bib0170","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eururo.2019.06.023","article-title":"Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a cochrane systematic review and meta-analysis","volume":"77","author":"Drost","year":"2020","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.purol.2023.10.001_bib0175","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.juro.2016.06.079","article-title":"Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR","volume":"196","author":"Rosenkrantz","year":"2016","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.purol.2023.10.001_bib0180","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.eururo.2008.06.043","article-title":"Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy","volume":"55","author":"Campos-Fernandes","year":"2009","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.purol.2023.10.001_bib0185","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/JU.0000000000001232","article-title":"Risk of prostate cancer after a negative magnetic resonance imaging guided biopsy","volume":"204","author":"Kinnaird","year":"2020","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.purol.2023.10.001_bib0190","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3348\/kjr.2018.19.4.733","article-title":"Yield of repeat targeted direct in-bore Magnetic Resonance-Guided prostate Biopsy (MRGB) of the same lesions in men having a prior negative targeted MRGB","volume":"19","author":"Venderink","year":"2018","journal-title":"Korean J Radiol"},{"issue":"5","key":"10.1016\/j.purol.2023.10.001_bib0195","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.eururo.2022.07.025","article-title":"Prostate cancer detection percentages of repeat biopsy in patients with positive multiparametric magnetic resonance imaging (prostate imaging reporting and data system\/Likert 3-5) and negative initial biopsy. A mini systematic review","volume":"82","author":"Grivas","year":"2022","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.purol.2023.10.001_bib0200","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1464-410X.2012.11611.x","article-title":"Prognostic Gleason grade grouping: data based on the modified Gleason scoring system: prognostic Gleason grade grouping","volume":"111","author":"Pierorazio","year":"2013","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.purol.2023.10.001_bib0205","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouvi\u00e8re","year":"2019","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.purol.2023.10.001_bib0210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging\u00a0\u2013\u00a0reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.purol.2023.10.001_bib0215","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/cancers12020285","article-title":"Independent evaluation of the respective predictive values for high-grade prostate cancer of clinical information and RNA biomarkers after upfront MRI and image-guided biopsies","volume":"12","author":"Roumigui\u00e9","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.purol.2023.10.001_bib0220","article-title":"Managing discordant findings between multiparametric magnetic resonance imaging and transrectal magnetic resonance imaging-directed prostate biopsy\u00a0\u2013\u00a0the key role of magnetic resonance imaging-directed transperineal biopsy","author":"Bajeot","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.purol.2023.10.001_bib0225","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/jcm9010225","article-title":"Assessment of the minimal targeted biopsy core number per MRI lesion for improving prostate cancer grading prediction","volume":"9","author":"Ploussard","year":"2020","journal-title":"JCM"},{"issue":"1","key":"10.1016\/j.purol.2023.10.001_bib0230","doi-asserted-by":"crossref","first-page":"13603","DOI":"10.1038\/s41598-022-17260-6","article-title":"Follow-up of men with a PI-RADS 4\/5 lesion after negative MRI\/Ultrasound fusion biopsy","volume":"12","author":"Kornienko","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.purol.2023.10.001_bib0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.euf.2023.03.011","article-title":"Magnetic resonance imaging follow-up of targeted biopsy\u00a0\u2013\u00a0negative prostate lesions","author":"Stavrinides","year":"2023","journal-title":"Eur Urol Focus"},{"issue":"3","key":"10.1016\/j.purol.2023.10.001_bib0240","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/JU.0000000000001424","article-title":"Followup of men with PI-RADS\u2122 4 or 5 abnormality on prostate magnetic resonance imaging and non-malignant pathological findings on initial targeted prostate biopsy","volume":"205","author":"Meng","year":"2021","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.purol.2023.10.001_bib0245","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00345-018-2337-0","article-title":"Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer?","volume":"37","author":"Gold","year":"2019","journal-title":"World J Urol"},{"issue":"5","key":"10.1016\/j.purol.2023.10.001_bib0250","first-page":"297e9","article-title":"The utility of in-bore multiparametric magnetic resonance-guided biopsy in men with negative multiparametric magnetic resonance-ultrasound software-based fusion targeted biopsy","volume":"39","author":"Perrin","year":"2021","journal-title":"Urol Oncol Semin Orig Invest"},{"issue":"12","key":"10.1016\/j.purol.2023.10.001_bib0255","doi-asserted-by":"crossref","first-page":"e0169120","DOI":"10.1371\/journal.pone.0169120","article-title":"Accuracy of elastic fusion of prostate magnetic resonance and transrectal ultrasound images under routine conditions: a prospective multi-operator study. He H, editor","volume":"11","author":"Moldovan","year":"2016","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.purol.2023.10.001_bib0260","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1148\/radiol.2017162916","article-title":"Precision matters in MR imaging-targeted prostate biopsies: evidence from a prospective study of cognitive and elastic fusion registration transrectal biopsies","volume":"287","author":"Cornud","year":"2018","journal-title":"Radiology"},{"issue":"3\u20134","key":"10.1016\/j.purol.2023.10.001_bib0265","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000504266","article-title":"Additive value of transrectal systematic ventral biopsies in combination with magnet resonance imaging\/ultrasound fusion-guided biopsy in patients with 3 or more negative prostate biopsies","volume":"104","author":"Maxeiner","year":"2020","journal-title":"Urol Int"},{"issue":"5","key":"10.1016\/j.purol.2023.10.001_bib0270","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.juro.2018.06.012","article-title":"The institutional learning curve of magnetic resonance imaging-ultrasound fusion targeted prostate biopsy: temporal improvements in cancer detection in 4 years","volume":"200","author":"Meng","year":"2018","journal-title":"J Urol"}],"container-title":["The French Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708723002373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708723002373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:55:38Z","timestamp":1761188138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708723002373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1166708723002373"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2023.10.001","relation":{},"ISSN":["2950-3930"],"issn-type":[{"value":"2950-3930","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significant prostate cancer risk after MRI-guided biopsy showing benign findings: Results from a cohort of 381 men","name":"articletitle","label":"Article Title"},{"value":"The French Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2023.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102547"}}